<DOC>
	<DOCNO>NCT01300052</DOCNO>
	<brief_summary>The purpose study determine whether AN2728 topical ointment safe effective treatment mild-to-moderate plaque-type psoriasis .</brief_summary>
	<brief_title>AN2728 Topical Ointment Treat Mild-to-Moderate Plaque-Type Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Clinical diagnosis stable mildtomoderate plaquetype psoriasis involve 235 % total body surface area ( BSA ) exclude face , scalp , genitals Willingness ability apply study medication direct , comply study instruction , commit attend study visit Women childbearing potential must agree use contraception entire study period Any dermatological condition could interfere clinical evaluation Concurrent recent use certain topical systemic medication without sufficient washout period Significant confounding condition assess study doctor Participated trial investigational drug within 30 day participation research study concurrent study Use lithium hydroxychloroquinecontaining product ( e.g. , Plaquenil ) Use betablocking medication ( e.g. , propranolol ) dose stabilize least 3 month Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>psoriasis</keyword>
</DOC>